|
|
The Healthcare World Has Finally Changed!!!\n...With Opportunities for Innovation Everywhere \nCabrillo Pavilion Arts Center, Santa Barbara, California\nWednesday, May 21, 2008 5:00pm – 9:00pm\n Map | Add to Calendar | Pricing Information\n\n\nWHO SHOULD ATTEND: \n\n• Anyone interested in how to turn widespread emerging issues and problems (not just in the healthcare field) into win-win solutions and attractive business models\n\n• Entrepreneurs\n\n• Investors, CEOs, service providers and managers of technology startups and emerging growth companies,\n\n• Anyone interested in the opportunities opening up as a result of the changing healthcare landscape and corporate wellness initiatives.\n\nEscalating healthcare costs are a huge concern to both employers and employees. Employers are reacting by promoting preventative healthcare and allocating budgets for wellness programs in the workplace. Employees are reacting to the increasing portion of healthcare costs being shifted to them by taking a more proactive stance and becoming increasingly involved in their own preventative healthcare programs. These trends are driving new and innovative approaches to preventative healthcare and wellness; which in turn are dramatically shifting the traditional healthcare delivery system and model.\n \n \nPresenting Firm: Justin J. Bellante, CEO, Co-founder and President, BioIQ, Inc. http://www.bioiq.com/ \n\nBioIQ, Inc., a Santa Barbara based healthcare information technology company, addresses this problem from both perspectives by providing at-home diagnostic testing for early detection of chronic diseases to support corporate wellness programs. BioIQ educates consumers and empowers them with more control and responsibility for their own health – and at the same time greatly enhances other corporate wellness initiatives at their firm.\n\nBioIQ’s consumer directed approach provides employees with convenient at-home test kits and comprehensive web-based communication tools and online reporting. The BioIQ program is currently being marketed through corporate wellness program providers as an add-on to existing corporate wellness programs. The BioIQ diagnostic screening program seamlessly integrates consumers, employers, and managed care organization to improve the efficacy of wellness and disease management. \n\n\n\nKeynote Speaker: Gale Wilson-Steele, founder MEDSEEK and CareSeek.\nPresentation: Consumer Driven Healthcare\nPeople are finding new and original ways of sharing information, creating online relationships and empowering themselves with health information. While many of these efforts will fade before they catch on, others will impact healthcare delivery. Gale Wilson-Steele, founder of MEDSEEK and the new CareSeek, talks about Health 2.0 innovations and how you can prepare yourself to exploit emerging trends impacting healthcare and its delivery.\n\nPanelists:\n \nStevan Birnbaum: Venture Capitalist, Managing Director Acturus Capital\n\nSusan Block: Investment Banker & Strategic Consultant, Block Bowman & Associates, LLC\n\nDavid Spaulding: Chief Technology Officer, Stellar Biotechnologies\n\nGale Wilson-Steele: CEO CareSeek, CEO, MedSeek, Founder and Chief Strategy Officer\n\nPanel Moderator: Leslie Edwards, PhD, Director of Corporate Business Development, University of California – Santa Barbara. \n\n\nLogistics:\n\nWHEN: \n Wednesday, May 21, 2008 \n Registration, Dinner, Cash Bar & Networking Hour: 5:00pm – 6:00pm \n Speakers and Panel: 6:00pm – 7:30pm \n Post Presentation Cash Bar available from 7:30pm \n \n WHERE: \n Cabrillo Pavilion Arts Center \n 1118 E. Cabrillo Boulevard, Santa Barbara, CA 93103 \n \n COST: \n $30 pre-register online before May 21 at www.centralcoastmit.com \n$40 on May 21, or at the door \n \n PARKING: \n $2.00 \n\n\n\nGale Wilson Steele \n\nCareSeek, CEO, MedSeek, Founder and Chief Strategy Officer\n\n\nGale Wilson-Steele, founded MedSeek, Inc. in 1996 with the mission of advancing communications on healthcare through Internet technology. Today MEDSEEK specializes in online healthcare solutions that empower patients, physicians, employees and consumers to securely exchange knowledge, interact with healthcare organizations and access medical records online. MEDSEEK is recognized as a leading portal solutions provider, and has enabled over 600 hospitals to effectively connect their stakeholders through portals, websites and Intranets. \n\n\nIn 2006, Gale applied her experiences in healthcare communication to a new vision, and established CareSeek in order to create an online resource for consumers seeking quality care. CareSeek.com is a member of the CareSeek consortium of websites and provides nurses, providers and CareSeekers with a platform for sharing their personal impressions of doctors from a professional perspective. Through the CareSeek community, patients, families and medical professionals have the opportunity to contribute to a balanced viewpoint and open sharing of experiences, providing healthcare consumers with the information they need to make better choices regarding their healthcare providers. Gale has also founded X2HN, a not-for-profit Women’s Executive Healthcare Network, to promote collaboration with colleagues, business partners and peers. http://x2hn.org . A graduate of Stanford University, Gale is married and has four children.\n\n\nSusan A. Block\nInvestment Banker & Strategic Consultant, Block, Bowman & Associates, LLC\nSusan has over 20 years experience as an investment banker, and strategic consultant in the Mergers & Acquisitions Group at Montgomery Securities, as a Vice President at Mercantile Capital Corporation, and most recently as a principal with Block, Bowman & Associates, LLC. While a member of the Mergers & Acquisitions Group at Montgomery Securities, Ms. Block worked on larger merger assignments across all industries and was responsible for the sale of Safeway’s Liquor Barn operations by Kohlberg, Kravis and Roberts. \nMs. Block’s background also includes working with firms in turnaround situations or in the start-up or early growth phases of their lifecycle. Ms. Block conceptualizes, develops and implements growth strategies for these firms incorporating risk-minimizing business models and a solid strategic and market focus. In many cases, these strategies culminate in a successful exit or merger for the principals and founders. Ms. Block has held positions as CEO and VP Corporate Planning and/or Advisory Board member for numerous firms. Ms. Block now works on merger assignments, growth strategies and other strategic advisory projects in a wide range of industries including software, information technology, healthcare, wireless, consumer goods and telecommunications.Ms. Block has served on the Advisory Board for LARTA (LA Regional Technology Alliance) as well as the Chair of the Business Plan and Mentoring Committee for the LARTA Venture Forum. In this capacity, and as a Mentor for firms involved in Technology Transfer Programs and other government programs to commercialize grant funded technology, Ms. Block has reviewed business plans, completed feasibility studies and mentored firms through the commercialization process for many years across most industry areas. Ms. Block received an MBA in finance and a Bachelors of Science from the University of Wisconsin, and has taught finance and business courses as a faculty member at the University of Wisconsin - School of Business Administration, the Department of Economics at UCSB and presently in the Technology Management Program at the University of California Santa Barbara – Engineering Department.\nJustin J. Bellante,\n\n Bio-IQ Co-founder, President & CEO\n\nJustin Bellante\\\\\\\\\\\\\\'s technical skills and experience make him a vital asset to the BioIQ management team. As the CEO, Bellante is responsible for guiding the strategy and execution of the business plan. Since the company\\\\\\\\\\\\\\'s inception, he has helped guide BioIQ from a mere concept to an established company. During this period, he has helped solidify corporate direction and strategic partners, develop the BioIQ diagnostic testing service, and build organizational and operational structure. In addition, he has helped assemble the BioIQ Medical Advisory Board.\n\n\nPrior to joining BioIQ, Bellante developed novel materials and testing platforms for Microelectromechanical Systems (MEMS) device fabrication and biological applications while pursuing his Ph.D. at the University of California, Santa Barbara. Bellante has additional experience as a researcher in the Radiation and Reliability Physics organization at the\nSandia National Laboratory and at the Microfabrication Facility within Case Western Reserve University (CWRU). These positions exposed him to a variety of research, technical, and manufacturing scenarios, all of which give him an in-depth understanding of product creation, development, and deployment-activities that are vital to the BioIQ mission.\n\n\nBellante holds a B.S. and an M.S. in Materials Engineering from CWRU, and is on leave from his Ph.D. program in Materials Engineering from the University of California, Santa Barbara. He has published articles in scientific journals such as Science, Applied Physics Letters, and MRS Proceedings.\n\n\nStevan Birnbaum\n\n Managing Director Acturus Capital\nhttp://www.arcturusvc.com/\n \n\nSteve Birnbaum is a Managing Director of Arcturus Capital and serves as the Chairman of the Investment Committee. Mr. Birnbaum has more than thirty years experience as a venture capitalist. He has led or made investments in more than 60 companies and has served as a general partner or equivalent of eight venture funds.\n \n\nMr. Birnbaum\\'s venture capital career began in 1969 when he founded Hohenberg & Associates, based in Los Angeles. With $5 million in committed capital, Hohenberg & Associates developed co-investment relationships with the leading California venture capitalists of the time, including Arthur Rock, Eugene Kleiner, Richard Riordan, David Goodman and others. In 1977 Mr. Birnbaum became a Principal in Xerox Development Corp. which was regarded as the most successful corporate venture capital organization of its time. Virtually all of the 16 technology investments made by Mr. Birnbaum\\'s group at Xerox were successful. Included in these investments were Apple Computer (NASDAQ: AAPL); INSERT INTO events2 (id, isopen, title, location, briefdescrip, ldescription, date, [current], attendees, map, [time], capacity, reminders, doorpay) VALUES Paradyne Corp. and Data I/O. \n \n\n In 1981 Mr. Birnbaum joined Oxford Partners where he headed the Southern California Office. Oxford Partners raised $125 million from institutions including major electronics, computer and telecommunications companies such as IBM, GE, Xerox and AT&T. Oxford Partners was the leading advocate of strategic investing. Over 50 of Oxford\\\\\\\\\\\\\\'s portfolio companies received strategic investments from partners including Intel, Sun Microsystems, Johnson & Johnson, and Sony. Among Mr. Birnbaum\\'s investments at Oxford Partners were Vitesse Semiconductor (NASDAQ: VTSS); INSERT INTO events2 (id, isopen, title, location, briefdescrip, ldescription, date, [current], attendees, map, [time], capacity, reminders, doorpay) VALUES Mosel-Vitelic and Micro General. In 1995, the Principals of Oxford Partners went on to form Oxford Bioscience primarily in the East and Mr. Birnbaum founded Oxcal Venture Fund in Los Angeles. Oxcal was an early stage technology fund that counted among its investments Gene Logic (NASDAQ: GLGC); INSERT INTO events2 (id, isopen, title, location, briefdescrip, ldescription, date, [current], attendees, map, [time], capacity, reminders, doorpay) VALUES Genta Pharmaceuticals (NASDAQ: GNTA); INSERT INTO events2 (id, isopen, title, location, briefdescrip, ldescription, date, [current], attendees, map, [time], capacity, reminders, doorpay) VALUES and Softcom Microsystems.\n \n\nMr. Birnbaum has lectured extensively on venture capital and mergers and acquisitions at Harvard, UCLA, USC, California State Univ. Northridge, and Pepperdine. He received a BS in Engineering from University of California Los Angeles, earning Tau Beta Pi and Phi Eta Sigma awards for academic excellence. He also received a Masters of Business Administration from Harvard Business School. \n\nDavid Spaulding\n\nChief Technology Officer, Stellar Biotechnologies\n\nDavid is currently Chief Technology Officer at Stellar Biotechnologies , an NIH-funded product-stage company that supplies platform technology for therapeutic vaccines. David’s 20 years in the biomedical industry have included leadership roles in R&D, manufacturing, marketing, and alliance creation for diagnostics and therapeutics. While at Dako Corporation, he was instrumental in forming the industry’s first predictive diagnostics partnerships for new targeted oncology therapies. He has been a consultant to biopharmaceutical companies and investors on matters of strategy, technology development, licensing, marketing, and due diligence for life science transactions. He is an advisor to Agility Capital LLC of Santa Barbara, the Technology Management Program at UCSB, and the Biotechnology Graduate Program at Cal State University, Channel Islands. David earned his Ph.D. in Biology and B.A. in Aquatic Biology from UCSB.\n |